Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke University, University of Kentucky, University of California, San Francisco, Huntsman Cancer Institute, Memorial Sloan Kettering Cancer Center, The Ohio State University Wexner Medical Center, The Ohio State University, University of Nebraska Medical Center, Saint Luke's Hospital, Stanford Cancer Institute, University of Alabama, University of Alabama at Birmingham, BioMimetix JV, LLC (United States), Gad Consulting Services (United States)
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4206156885
